Literature DB >> 28794692

Deracemization of a Racemic Allylic Sulfoxide Using Viedma Ripening.

Anthonius H J Engwerda1, Niels Koning1, Paul Tinnemans1, Hugo Meekes1, F Matthias Bickelhaupt1,2, Floris P J T Rutjes1, Elias Vlieg1.   

Abstract

Despite the importance of enantiopure chiral sulfoxides, few methods exist that allow for their deracemization. Here, we show that an enantiopure sulfoxide can be produced from the corresponding racemate using Viedma ripening involving rearrangement-induced racemization. The suitable candidate for Viedma ripening was identified from a library of 24 chiral sulfoxides through X-ray structure determination. Starting from the racemic sulfoxide, an unprecedented application of a 2,3-sigmatropic rearrangement type racemization in a Viedma ripening process allowed for complete deracemization.

Entities:  

Year:  2017        PMID: 28794692      PMCID: PMC5543398          DOI: 10.1021/acs.cgd.7b00828

Source DB:  PubMed          Journal:  Cryst Growth Des        ISSN: 1528-7483            Impact factor:   4.076


Introduction

Single chirality is a key feature of life and hence of utmost importance in the production of active pharmaceutical ingredients in the pharmaceutical industry. In the case of chiral drugs, it is generally one enantiomer that has the desired physiological effects, whereas its mirror image is inactive or even has harmful consequences.[1] An important class of drugs consists of chiral sulfoxides, where a sulfur instead of a carbon atom is the tetrahedral center of chirality. The best-known example of a chiral sulfoxide is probably esomeprazole, the number two selling drug in 2013 in the United States (marketed as Nexium). This drug acts as a proton pump inhibitor, reducing stomach acid production.[2] Esomeprazole is an enantiopure sulfoxide that is produced on an industrial scale by asymmetric oxidation of the corresponding sulfide.[3] It contains only the (S)-enantiomer and was found to be more active than the racemate, known as omeprazole.[4,5] Obtaining an enantiopure compound, however, is generally not straightforward, since (achiral) synthesis will yield both enantiomers in equal amounts, while enantioselective methods in many cases cannot be easily applied. In the majority of cases, resolution using diasteriomeric salt formation is applied to obtain the desired enantiomer, which, however, results in a maximum yield of 50%. As an alternative, a deracemization method might be applied, allowing yields of a single enantiomer in up to 100% yield.[6] Viedma ripening is such a method that allows the conversion of a racemic mixture of solids into a single enantiomer in theoretically 100% yield.[7,8] It involves grinding of a suspension of racemic conglomerate crystals in combination with racemization in solution, resulting in complete deracemization of the solid phase. The scope of Viedma ripening, however, has so far remained limited due to the lack of suitable racemization strategies.[9] The majority of examples consist of base-induced racemization through deprotonation, or involve a redox reaction. Consequently, examples of molecules that have been deracemized with Viedma ripening include amino acids[10] and derivatives,[11] and metalorganic complexes.[12] In addition, the group of Håkansson demonstrated Viedma ripening and successive oxidation on a ruthenium-sulfide complex.[13] However, due to the limitations in racemization methods, and despite the relevance of chiral sulfoxides in drugs, no such molecules have yet been deracemized using Viedma ripening. The purpose of our study is therefore to expand the scope of Viedma ripening to this important class of chiral molecules. In this article, we describe the route that we used to screen for a suitable sulfoxide and disclose the first example of deracemization of a sulfoxide using Viedma ripening.

Results and Discussion

A few challenges need to be faced before this particular case of Viedma ripening can be applied. First, the molecule of interest must be able to undergo racemization in solution. While the majority of sulfoxides racemize at temperatures over 200 °C,[14] allylic sulfoxides racemize at much lower temperatures (even below 50 °C[15]) since they are prone to undergo a 2,3-sigmatropic rearrangement, known as the Mislow–Evans rearrangement (Figure ).[16−18] Such an intramolecular rearrangement is unprecedented as the racemization mechanism in Viedma ripening.
Figure 1

An allylic sulfoxide can reversibly rearrange into an achiral sulfenate via a 2,3-sigmatropic rearrangement, resulting in solution phase racemization of the chiral sulfoxide.

An allylic sulfoxide can reversibly rearrange into an achiral sulfenate via a 2,3-sigmatropic rearrangement, resulting in solution phase racemization of the chiral sulfoxide. A second requirement for Viedma ripening is that the enantiomers crystallize as separate crystals, i.e., form a racemic conglomerate. For the majority (∼90%) of compounds, however, the enantiomers crystallize in the same crystal, i.e., form a racemic compound. Thus, the first step in this project is to identify a conglomerate allylic sulfoxide. Since no such conglomerate has been posted in the Cambridge Structural Database (CSD) up to now, we first performed a screening. Salt formation has been described as a route for finding conglomerate crystals.[19] However, since many sulfoxides are not compatible with salt formation, we decided to engage in a library synthesis. A series of 24 sulfoxides was synthesized to ensure a reasonable chance of finding a conglomerate (Figure , see Supporting Information for a complete overview). To identify sulfoxides displaying conglomerate behavior, crystals suitable for X-ray analysis were grown using slow solvent evaporation. From the 24 synthesized compounds, crystals could be grown of 14 of them, from which we found that compound 1 crystallized as a racemic conglomerate. All other compounds crystallized as racemic compounds (Figure ).
Figure 2

A series of 24 allylic chiral sulfoxides were synthesized, of which crystal structures could be determined for 14 of them (space groups are given after the compound number). Of these 14, only compound 1 crystallized as a racemic conglomerate.

A series of 24 allylic chiral sulfoxides were synthesized, of which crystal structures could be determined for 14 of them (space groups are given after the compound number). Of these 14, only compound 1 crystallized as a racemic conglomerate. Compound 1 was subsequently used for the Viedma ripening experiments. The speed of racemization of allylic chiral sulfoxides is highly solvent dependent.[20] We found that racemization of compound 1 takes place at room temperature in apolar solvents such as toluene and diethyl ether, while the optical purity of the sulfoxide can be retained in polar solvents such as methanol (t1/2 > 4 days at RT). By using toluene at room temperature as a solvent and starting from completely racemic conditions, an enantiomeric excess (ee) of 12% was obtained after a period of over a month. These promising results prompted us to investigate the racemization kinetics, in order to reduce the deracemization time. We found a relatively high barrier for the racemization of 1 in toluene at room temperature according to both density functional theory (DFT) calculations (ΔH = 18.1 kcal/mol)[21] and temperature dependent selective exchange spectroscopy experiments (ΔH = 21.2 kcal/mol). This barrier leads to a relatively long racemization half-life (t1/2 = 6.9 h) and results in slow deracemization. We therefore decided to increase the temperature in order to reduce the deracemization time. By changing the solvent system to refluxing diethyl ether (t1/2 = 6.3 h at RT and 1.1 h at reflux, bp 35 °C) and creating a small initial bias (around 1% ee), complete deracemization of 1 could be achieved in just 8 days (Figure ).
Figure 3

Viedma ripening of compound 1 in refluxing diethyl ether starting from the racemic conglomerate compound or metastable racemic compound. In both cases the suspension was seeded with enantiopure crystals.

Viedma ripening of compound 1 in refluxing diethyl ether starting from the racemic conglomerate compound or metastable racemic compound. In both cases the suspension was seeded with enantiopure crystals. In order to further decrease the deracemization time, the temperature was further increased to 50 °C. Since this temperature exceeds the boiling point of diethyl ether, the solvent was changed to toluene. Under these conditions, however, deracemization experiments of compound 1 were unsuccessful due to melting of the compound. When the solution was then cooled again, 1 recrystallized as a different polymorph with a lower melting point. We found that this low melting polymorph was in fact a metastable racemic compound (see Supporting Information). We have shown in a previous study that the speed of Viedma ripening can be increased using such a metastable racemic compound in combination with enantiopure seed crystals.[22] Hence, we investigated whether this same approach could be applied to reduce the deracemization time of chiral sulfoxide 1. Indeed, by starting from the racemic compound in combination with enantiopure seed crystals in refluxing diethyl ether, the deracemization time could be further decreased to 3 days (Figures and 4).
Figure 4

Grinding of a suspension of compound 1 in diethyl ether results in complete solid phase deracemization. By performing similar experiments at 50 °C in toluene, occasional melting and recrystallization resulted in the racemic compound and no deracemization. When grinding a suspension of this racemic compound, seeded with enantiopure crystals in refluxing diethyl ether, fast deracemization could be achieved.

Grinding of a suspension of compound 1 in diethyl ether results in complete solid phase deracemization. By performing similar experiments at 50 °C in toluene, occasional melting and recrystallization resulted in the racemic compound and no deracemization. When grinding a suspension of this racemic compound, seeded with enantiopure crystals in refluxing diethyl ether, fast deracemization could be achieved.

Conclusion

We have demonstrated that Viedma ripening can be used to deracemize chiral sulfoxides. By synthesizing 24 chiral allylic sulfoxides which spontaneously racemize through a 2,3-signatropic rearrangement at elevated temperatures in solution, one racemic conglomerate compound, suitable for Viedma ripening, was identified. Chiral amplification was achieved for this compound by simply heating a suspension of the molecule under grinding conditions. This experimentally facile route allows for the straightforward preparation of an enantiopure allylic sulfoxide. That this was done for one compound out of a library of 24 candidates might be considered as a limitation. However, similar enantiopure allylic sulfoxides have been used as chiral pool starting materials, and as chiral auxiliaries for the synthesis of enantiopure acids and esters.[23] Therefore, one deracemized compound can be the starting point for several enantiopure compounds. In addition, the present Viedma ripening screening not only demonstrates the preparation of a specific enantiopure sulfoxide, but also shows a general route that can be followed for the deracemization of other compounds.
  15 in total

Review 1.  A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole.

Authors:  Lars Olbe; Enar Carlsson; Per Lindberg
Journal:  Nat Rev Drug Discov       Date:  2003-02       Impact factor: 84.694

2.  Emergence of a single solid chiral state from a nearly racemic amino acid derivative.

Authors:  Wim L Noorduin; Toshiko Izumi; Alessia Millemaggi; Michel Leeman; Hugo Meekes; Willem J P Van Enckevort; Richard M Kellogg; Bernard Kaptein; Elias Vlieg; Donna G Blackmond
Journal:  J Am Chem Soc       Date:  2008-01-04       Impact factor: 15.419

3.  Attrition-enhanced deracemization of an amino acid derivative that forms an epitaxial racemic conglomerate.

Authors:  Bernard Kaptein; Wim L Noorduin; Hugo Meekes; Willem J P van Enckevort; Richard M Kellogg; Elias Vlieg
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

4.  A different approach to enantioselective organic synthesis: absolute asymmetric synthesis of organometallic reagents.

Authors:  Anders Lennartson; Susanne Olsson; Jonas Sundberg; Mikael Håkansson
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 5.  Recent advances in enzymatic and chemical deracemisation of racemic compounds.

Authors:  Michał Rachwalski; Niek Vermue; Floris P J T Rutjes
Journal:  Chem Soc Rev       Date:  2013-09-24       Impact factor: 54.564

6.  Viedma ripening: a reliable crystallisation method to reach single chirality.

Authors:  Leyla-Cann Sögütoglu; René R E Steendam; Hugo Meekes; Elias Vlieg; Floris P J T Rutjes
Journal:  Chem Soc Rev       Date:  2015-10-07       Impact factor: 54.564

7.  Speeding up Viedma ripening.

Authors:  Anthonius H J Engwerda; Hugo Meekes; Bernard Kaptein; Floris P J T Rutjes; Elias Vlieg
Journal:  Chem Commun (Camb)       Date:  2016-10-04       Impact factor: 6.222

8.  Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators.

Authors:  P J Kahrilas; G W Falk; D A Johnson; C Schmitt; D W Collins; J Whipple; D D'Amico; B Hamelin; B Joelsson
Journal:  Aliment Pharmacol Ther       Date:  2000-10       Impact factor: 8.171

9.  Absolute asymmetric synthesis: protected substrate oxidation.

Authors:  Susanne Olsson; Per Martin Björemark; Theonitsa Kokoli; Jonas Sundberg; Anders Lennartson; Christine J McKenzie; Mikael Håkansson
Journal:  Chemistry       Date:  2015-02-12       Impact factor: 5.236

10.  Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.

Authors:  J E Richter; P J Kahrilas; J Johanson; P Maton; J R Breiter; C Hwang; V Marino; B Hamelin; J G Levine
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

View more
  4 in total

1.  Combining Viedma Ripening and Temperature Cycling Deracemization.

Authors:  Giuseppe Belletti; Jelle Schuurman; Hester Stinesen; Hugo Meekes; Floris P J T Rutjes; Elias Vlieg
Journal:  Cryst Growth Des       Date:  2022-01-31       Impact factor: 4.076

2.  Synthesis of Enantiopure Sulfoxides by Concurrent Photocatalytic Oxidation and Biocatalytic Reduction.

Authors:  Sarah Bierbaumer; Luca Schmermund; Alexander List; Christoph K Winkler; Silvia M Glueck; Wolfgang Kroutil
Journal:  Angew Chem Int Ed Engl       Date:  2022-03-04       Impact factor: 16.823

3.  Solid Phase Deracemization of an Atropisomer.

Authors:  Anthonius H J Engwerda; Pim van Schayik; Henjo Jagtenberg; Hugo Meekes; Floris P J T Rutjes; Elias Vlieg
Journal:  Cryst Growth Des       Date:  2017-09-13       Impact factor: 4.076

4.  Solid-Phase Conversion of Four Stereoisomers into a Single Enantiomer.

Authors:  Anthonius H J Engwerda; Johannes C J Mertens; Paul Tinnemans; Hugo Meekes; Floris P J T Rutjes; Elias Vlieg
Journal:  Angew Chem Int Ed Engl       Date:  2018-10-19       Impact factor: 15.336

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.